Kyorin Pharmaceutical Co.,ltd.TSE: 4569

KYORIN Pharmaceutical: Sales and profits rose, but net income fell; full-year outlook expects modest growth

· Issued by Kyorin Pharmaceutical Co.,ltd.

Net sales and profits increased modestly year-over-year, but net income and comprehensive income declined. Full-year guidance projects continued sales and profit growth, though net income is expected to decrease.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.